Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma

NCT04682158 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

106

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Adenocarcinoma

Interventions

DRUG: Carboplatin
RADIATION: 3 Dimensional Conformal Radiation Therapy
DRUG: Propranolol
RADIATION: Intensity Modulated Radiation Therapy
DRUG: Paclitaxel

Sponsor

Roswell Park Cancer Institute